000 03748nam a2200433 i 4500
999 _c361294
_d361294
001 361294
003 ES-MaUEC
005 20230102121338.0
006 a||||fo|||| 00| 0
007 cr nn nnnaamaa
008 211005s2021 sz | o |||| 0|eng d
020 _a9783030762636
024 7 _a10.1007/978-3-030-76263-6
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRC270.8
_b2021 EB
245 0 0 _aCancer Nanotheranostics :
_bVolume 2
_cedited by Muthupandian Saravanan, Hamed Barabadi
250 _aFirst edition 2021
264 1 _aCham
_bSpringer International Publishing
_c2021
300 _a1 recurso en línea (XIV, 368 páginas)
_b49 ilustraciones, 47 ilustraciones a color
336 _2rdacontent
_aTexto
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _aArchivo de texto
_bPDF
490 0 _aNanotechnology in the Life Sciences
_x2523-8035
490 0 _aBiomedical and Life Sciences (SpringerNature-11642)
490 0 _aBiomedical and Life Sciences (R0) (SpringerNature-43708)
505 0 _aPreface -- Nanotheranostics -- Multifunctional Nanoparticles for Targeting Cancer Nanotheranostics -- Nano-Oncology -- Cancer-Targeted Nanotheranostics -- Nanotheranostics -- Cancer Nano-Immunotherapy -- Recent Advances in Lipid-Based Nanoformulations for Breast Cancer Theranostics -- Nanoparticle for Photoresponsive Minimal-Invasive Cancer Therapy -- Biologically Synthesized Plant-Derived Nanomedicines and their In-Vitro In-Vivo Toxicity Studies in Various Cancer Therapeutics -- Nanoerythrosome -- Role of Artificial Intelligence in Cancer Nanotheranostics -- Limitations of Current Cancer Nanotheranositcs -- Safety of nanobiomaterials for Cancer Nanotheranostics -- Index.
520 3 _aCancer Nanotheranostics, Volume 2 continues the discussion of the important work being done in this field of cancer nanotechnology. The contents of these two volumes are explained in detail as follows. In the first volume of Cancer Nanotheranostics, we discussed the role of different nanomaterials for cancer therapy including lipid-based nanomaterials, protein and peptide-based nanomaterials, polymer-based nanomaterials, metal-organic nanomaterials, porphyrin-based nanomaterials, metal-based nanomaterials, silica-based nanomaterials, exosome-based nanomaterials, and nano-antibodies. This important second volume discusses nano-based diagnosis of cancer, nano-oncology for clinical applications, nano-immunotherapy, nano-based photothermal cancer therapy, nanoerythrosomes for cancer drug delivery, regulatory perspectives of nanomaterials, limitations of cancer nanotheranostics, safety of nanobiomaterials for cancer nanotheranostics, multifunctional nanomaterials for targeting cancer nanotheranostics, and the role of artificial intelligence in cancer nanotheranostics. Volume 2 is a vital continuation of this two-volume set. Together, these two volumes create a comprehensive and unique examination of this important area of research.
988 _aSpringer_BiomedLife_2021
650 7 _2embne
_9174085
_aCáncer
_xTratamiento
700 1 _aSaravanan, Muthupandian,
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_9680913
_d1977-
700 1 _aBarabadi, Hamed
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_9680914
776 0 8 _iPrinted edition:
_z9783030762629
776 0 8 _iPrinted edition:
_z9783030762643
776 0 8 _iPrinted edition:
_z9783030762650
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-76263-6
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _b01/2022
_dz
_eb
_zSI